ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,284.91
0.20%
Dow Jones
42,174.84
0.62%
Gold vs US Dollar
2,670.71
0.51%
Brent Oil
71.085
-2.88%
Bitcoin
65,247.49
3.35%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Personalis Inc (PSNL)

  7. Personalis Inc (PSNL) News

Personalis (PSNL)

Personalis Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PSNL
DateTimeSourceHeadlineSymbolCompany
19/09/202422:28Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PSNLPersonalis Inc
16/09/202414:00Business WireESMO 2024 Data Expands on Compelling Performance of Personalis NeXT Personal® MRD TestNASDAQ:PSNLPersonalis Inc
12/09/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PSNLPersonalis Inc
30/08/202421:43Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:PSNLPersonalis Inc
22/08/202421:01Business WirePersonalis to Participate at Upcoming Investor ConferencesNASDAQ:PSNLPersonalis Inc
20/08/202421:27Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:PSNLPersonalis Inc
20/08/202421:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSNLPersonalis Inc
19/08/202421:05Business WirePersonalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PSNLPersonalis Inc
16/08/202414:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PSNLPersonalis Inc
16/08/202413:30Business WirePersonalis and Tempus Announce Expanded CollaborationNASDAQ:PSNLPersonalis Inc
07/08/202421:35Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PSNLPersonalis Inc
07/08/202421:01Business WirePersonalis Reports Second Quarter 2024 Financial ResultsNASDAQ:PSNLPersonalis Inc
07/08/202421:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PSNLPersonalis Inc
06/08/202421:05GlobeNewswire Inc.Myriad Genetics Reports Strong Second Quarter 2024 Financial Results, including 15% Revenue Growth Year-Over-Year; Raises 2024 Financial Guidance and Long-Term Revenue Growth Target to 12%NASDAQ:PSNLPersonalis Inc
01/08/202422:16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSNLPersonalis Inc
01/08/202422:16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSNLPersonalis Inc
31/07/202421:01Business WirePersonalis to Participate at the 9th Annual Needham Virtual MedTech & Diagnostics 1x1 ConferenceNASDAQ:PSNLPersonalis Inc
24/07/202421:01Business WirePersonalis to Announce Second Quarter 2024 Financial ResultsNASDAQ:PSNLPersonalis Inc
11/07/202414:00GlobeNewswire Inc.Myriad Genetics and Personalis Cross-License Foundational MRD Intellectual Property to Broaden Patient Access to TestingNASDAQ:PSNLPersonalis Inc
18/06/202421:01Business WirePersonalis to Participate at the TD Cowen 3rd Annual Tools / Dx Revolution ConferenceNASDAQ:PSNLPersonalis Inc
13/06/202413:00Business WirePersonalis Provides Dial-in and Updated Date for ASCO Highlights Conference CallNASDAQ:PSNLPersonalis Inc
04/06/202421:05Business WireASCO Data Highlights NeXT Personal® Ultra-sensitive MRD Performance in Early-stage Breast Cancer Recurrence Detection and Immunotherapy MonitoringNASDAQ:PSNLPersonalis Inc
31/05/202414:05Business WirePersonalis Announces Start of Cancer MRD Testing Commercialization Collaboration with TempusNASDAQ:PSNLPersonalis Inc
22/05/202414:05Business WirePersonalis Announces Podium Presentations and Abstracts Accepted at ASCO 2024NASDAQ:PSNLPersonalis Inc
22/05/202402:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSNLPersonalis Inc
22/05/202402:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSNLPersonalis Inc
21/05/202421:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PSNLPersonalis Inc
17/05/202421:05Business WirePersonalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PSNLPersonalis Inc
08/05/202421:01Business WirePersonalis Reports First Quarter 2024 Financial ResultsNASDAQ:PSNLPersonalis Inc
08/05/202421:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PSNLPersonalis Inc
 Showing the most relevant articles for your search:NASDAQ:PSNL

Your Recent History

LSE
43KF
Trafford A4
BIT
P1DD20
BNP Paribas Issuance
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved